Medyssey Co., Ltd.
KKRX:20058012,000.00
KRW
0.00
(0.00%)
ISIN
KR7200580009
Return %
Stock
S&P 500
1Y
9.29
14.20
3Y
11.11
81.12
5Y
1.27
68.34
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Gyung-Soo Seong
- Full Time Employees
- 101
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Jecheon-si South Korea
- IPO Date
- Oct 20, 2015
- Website
- medyssey.co.kr
- Similar Companies
- Business
- Medyssey Co., Ltd. is a South Korea-based medical device company that develops, manufactures, and markets orthopedic and neurosurgical spinal implants and surgical instrumentation. The company specializes in spinal fusion and anatomical reconstruction technologies, providing a comprehensive portfolio that includes thoracolumbar pedicle screw fixation systems, such as the Iliad and Zenius systems; minimally invasive spinal fixation platforms, including the ARTeMIS system; anterior cervical plating systems, such as Athena; interbody fusion cages fabricated from polyetheretherketone (PEEK) and titanium, including the MEDUSSA II, Triton, Varian, and Medussa-PL cage lines for posterior and transforaminal lumbar fusion; custom patient-specific 3D-printed titanium implants, including the MCS cranial reconstructive system and the MCB system for complex bone defect reconstruction in the pelvis and lower extremities; and specialized surgical instruments and retractor sets designed for open and minimally invasive spine surgeries. Operating as a core medical device subsidiary of Dong Wha Pharm Co., Ltd., Medyssey serves orthopedic surgeons, neurosurgeons, hospitals, and medical centers across domestic and international markets spanning North America, Latin America, Europe, the Middle East, and Asia, supported by foreign operating units including Medyssey USA, Inc. in the United States and Medyssey S.A. in Chile. In recent developments, Medyssey has driven significant global expansion of its proprietary 3D-printed porous titanium implant portfolio, achieving double-digit growth in export revenues across more than 25 international markets. The company has also broadened the clinical applications of its patient-specific customized implant technologies while advancing strategic preparations to transfer its stock listing from the Korea New Exchange (KONEX) to the KOSDAQ market. Founded in 2003 and formerly known as Varian Co., Ltd. before rebranding in 2007, Medyssey Co., Ltd. is headquartered in Jecheon-si, Chungcheongbuk-do, South Korea, with an additional corporate office in Seoul, South Korea.